Evidence map›Paper›PMID 28872641›Full record

ArticleTranslational psychiatry2017

Polyunsaturated fatty acid deficiency during neurodevelopment in mice models the prodromal state of schizophrenia through epigenetic changes in nuclear receptor genes.

M Maekawa, A Watanabe, Y Iwayama, T Kimura, K Hamazaki, S Balan, H Ohba, Y Hisano, Y Nozaki, T Ohnishi and 8 more

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. The Potential of Hair Matrix for Biomarker Analysis in Schizophrenia.International journal of molecular sciences · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

M MaekawaLaboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
A WatanabeLaboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
Y IwayamaLaboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
T KimuraDepartment of Alzheimer's Disease Research, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, Aichi, Japan.
K HamazakiDepartment of Public Health, Faculty of Medicine, University of Toyama, Toyama, Japan.
S BalanLaboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.ORCID 0000-0002-1098-1290
H OhbaLaboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
Y HisanoLaboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
Y NozakiLaboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
T OhnishiLaboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
M ToyoshimaLaboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
C ShimamotoLaboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
K IwamotoDepartment of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
M BundoDepartment of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
N OsumiDepartment of Developmental Neuroscience, Tohoku University Graduate School of Medicine, Sendai, Japan.
E TakahashiSupport Unit for Animal Resources Development, RIKEN Brain Science Institute, Saitama, Japan.
A TakashimaLaboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
T YoshikawaLaboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
RIKEN Center for Brain Science · JPKumamoto University · JPNational Center for Geriatrics and Gerontology · JPTohoku University · JPUniversity of Toyama · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The risk of schizophrenia is increased in offspring whose mothers experience malnutrition during pregnancy. Polyunsaturated fatty acids (PUFAs) are dietary components that are crucial for the structural and functional integrity of neural cells, and PUFA deficiency has been shown to be a risk factor for schizophrenia. Here, we show that gestational and early postnatal dietary deprivation of two PUFAs-arachidonic acid (AA) and docosahexaenoic acid (DHA)-elicited schizophrenia-like phenotypes in mouse offspring at adulthood. In the PUFA-deprived mouse group, we observed lower motivation and higher sensitivity to a hallucinogenic drug resembling the prodromal symptoms in schizophrenia. Furthermore, a working-memory task-evoked hyper-neuronal activity in the medial prefrontal cortex was also observed, along with the downregulation of genes in the prefrontal cortex involved in oligodendrocyte integrity and the gamma-aminobutyric acid (GABA)-ergic system. Regulation of these genes was mediated by the nuclear receptor genes Rxr and Ppar, whose promoters were hyper-methylated by the deprivation of dietary AA and DHA. In addition, the RXR agonist bexarotene upregulated oligodendrocyte- and GABA-related gene expression and suppressed the sensitivity of mice to the hallucinogenic drug. Notably, the expression of these nuclear receptor genes were also downregulated in hair-follicle cells from schizophrenia patients. These results suggest that PUFA deficiency during the early neurodevelopmental period in mice could model the prodromal state of schizophrenia through changes in the epigenetic regulation of nuclear receptor genes.

Indexed as

Cognitive DysfunctionPrefrontal CortexPrenatal Exposure Delayed EffectsSchizophreniaAnimalsAnimals, NewbornArachidonic AcidBehavior, AnimalDisease Models, AnimalDocosahexaenoic AcidsEpigenesis, GeneticFemaleMalnutritionMiceMice, Inbred C57BLMilk, HumanArachidonic AcidDocosahexaenoic AcidsReceptors, Cytoplasmic and Nuclear

Identifiers

PMID28872641
PMCPMC5639238
OpenAlexW2750993168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.